<p>Two sputum samples are to be collected, one as early morning and the other as spot sample. (Source: Revised National Tuberculosis Control Programme’s Revised Module 1–4, April 2011).</p>*<p>The intensive Phase is extended by four weeks (12 doses) in initially smear positive PTB patients who continue to be positive at the end of the 2 months of IP.</p>#<p>Early morning and spot specimens will be collected on this day.</p>**<p>The numbers during the IP represent doses of anti-TB drugs, wheras during the CP they represent weekly blister packs of anti-TB drugs.</p><p><u>Note:</u> For “<u>New” patients</u>, the intensive phase lasts for two months (8 weeks, 24 doses) and is followed by the continuation phase of four months (18 weekly blister ...
A country-wide survey was carried out to assess the management of new smear-positive pulmonary TB (P...
The Indian guidelines on following up sputum smear-negative Pulmonary tuberculosis (PTB) patients di...
Drug-resistant tuberculosis (DR-TB) is a worldwide global burden and related to poor treatment outco...
<p>Treatment duration and timing of follow-up sputum smear examinations for new and previously-treat...
<p>Mid-CP follow-up refers to the sputum smear microscopy which is scheduled between the 4<sup>th</s...
<p>IP = Intensive Phase; CP = Continuation Phase; Rx = Treatment; Ext = Extended Intensive phase; N ...
The Revised National Tuberculosis Control Program (RNTCP) of India recommends follow-up sputum smear...
The Revised National Tuberculosis Control Program (RNTCP) of India recommends follow-up sputum smear...
SETTING: All 44 non-private hospitals (four central, 22 district and 18 mission) in Malawi that regi...
BACKGROUND: The Revised National Tuberculosis Control Program (RNTCP) of India recommends follow-up ...
Background: The Revised National Tuberculosis Control Program (RNTCP) of India recommends follow-up ...
Background: According to Revised National Tuberculosis Control Program (RNTCP), diagnosis of pulmona...
<p>*In children, seriously ill sputum smear-negative Pulmonary Tuberculosis (PTB) includes all forms...
Introduction: In the patients with smear-positive pulmonary tuberculosis (TB) bacteriologic assessme...
Abstract: Background: Direct sputum smear microscopy is the cornerstone for the diagnosis of pulmona...
A country-wide survey was carried out to assess the management of new smear-positive pulmonary TB (P...
The Indian guidelines on following up sputum smear-negative Pulmonary tuberculosis (PTB) patients di...
Drug-resistant tuberculosis (DR-TB) is a worldwide global burden and related to poor treatment outco...
<p>Treatment duration and timing of follow-up sputum smear examinations for new and previously-treat...
<p>Mid-CP follow-up refers to the sputum smear microscopy which is scheduled between the 4<sup>th</s...
<p>IP = Intensive Phase; CP = Continuation Phase; Rx = Treatment; Ext = Extended Intensive phase; N ...
The Revised National Tuberculosis Control Program (RNTCP) of India recommends follow-up sputum smear...
The Revised National Tuberculosis Control Program (RNTCP) of India recommends follow-up sputum smear...
SETTING: All 44 non-private hospitals (four central, 22 district and 18 mission) in Malawi that regi...
BACKGROUND: The Revised National Tuberculosis Control Program (RNTCP) of India recommends follow-up ...
Background: The Revised National Tuberculosis Control Program (RNTCP) of India recommends follow-up ...
Background: According to Revised National Tuberculosis Control Program (RNTCP), diagnosis of pulmona...
<p>*In children, seriously ill sputum smear-negative Pulmonary Tuberculosis (PTB) includes all forms...
Introduction: In the patients with smear-positive pulmonary tuberculosis (TB) bacteriologic assessme...
Abstract: Background: Direct sputum smear microscopy is the cornerstone for the diagnosis of pulmona...
A country-wide survey was carried out to assess the management of new smear-positive pulmonary TB (P...
The Indian guidelines on following up sputum smear-negative Pulmonary tuberculosis (PTB) patients di...
Drug-resistant tuberculosis (DR-TB) is a worldwide global burden and related to poor treatment outco...